Catalyst Wire Dossier Catalyst Wire Dossier

Lipegfilgrastim

lipegfilgrastim · Teva Branded Pharmaceutical Products R&D, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Lipegfilgrastim, covering 2022-06-08 to 2022-06-08. Get the full timeline:

Most recent: Clinical Trial Update: A comparatiVe Study on Efficacy and Safety of Lipegfilgrastim in Comparison to Pegfilgrastim in Elderly Patients With Aggressive B Cell Non-HOdgkin Lymphomas at hIgh Risk for R-CHOP-21-inDuced Neutropenia [Phase 3]

See pricing